Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Argenx unexpectedly scrapped a study of its drug, Vyvgart, in patients with Sjogren’s disease on Thursday. The stock plummeted in response.
The post Former Highflier Argenx Plummets On A Surprise Setback In Sjogren’s appeared first on Investor’s Business Daily.
